Long-Lived Plasma Cells Are Contained within the CD19−CD38hiCD138+ Subset in Human Bone Marrow-Reference-Cited by-同舟云学术

Long-Lived Plasma Cells Are Contained within the CD19−CD38hiCD138+ Subset in Human Bone Marrow

Published:2015-07 Issue:1 Volume:43 Page:132-145
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Halliley Jessica L.,Tipton Christopher M.,Liesveld Jane,Rosenberg Alexander F.,Darce Jaime,Gregoretti Ivan V.,Popova Lana,Kaminiski Denise,Fucile Christopher F.,Albizua Igor,Kyu Shuya,Chiang Kuang-Yueh,Bradley Kyle T.,Burack Richard,Slifka Mark,Hammarlund Erika,Wu Hao,Zhao Liping,Walsh Edward E.,Falsey Ann R.,Randall Troy D.,Cheung Wan Cheung,Sanz Iñaki,Lee F. Eun-Hyung

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference50 articles.

1. Maintenance of the plasma cell pool is independent of memory B cells;Ahuja;Proc. Natl. Acad. Sci. USA,2008

2. IMGT/HighV-QUEST: the IMGT(R) web portal for immunoglobulin (IG) or antibody and T cell receptor (TR) analysis from NGS high throughput and deep sequencing;Alamyar;Immunome Res.,2012

3. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity;Amanna;Immunol. Rev.,2010

4. Duration of humoral immunity to common viral and vaccine antigens;Amanna;N. Engl. J. Med.,2007

5. Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage;Avery;J. Immunol.,2005

Cited by 416 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potentials of adoptive cell therapy in immune-mediated neuropathy;Journal of Autoimmunity;2024-12

2. Role of cellular effectors in the induction and maintenance of IgA responses leading to protective immunity against enteric bacterial pathogens;Frontiers in Immunology;2024-09-11

3. The Divergent Effect of Different Infant Vaccination Schedules of the 13-Valent Pneumococcal Conjugate Vaccine on Serotype-Specific Immunological Memory;Vaccines;2024-09-07

4. Remodeling the hepatic immune microenvironment and demolishing T cell traps to enhance immunotherapy efficacy in liver metastasis;Journal of Controlled Release;2024-09

5. Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody–Positive Primary Membranous Nephropathy;Kidney International Reports;2024-09